FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $1.86, $0.26 better than the analyst estimate of $1.60. Revenue for the quarter came in at $1.93 billion versus the consensus estimate of $1.92 billion.
"We had a solid fourth quarter and ended the year by delivering record revenues, earnings... More

